4:51 PM
 | 
Jan 03, 2013
 |  BC Extra  |  Company News

FDA committee to discuss low-dose paroxetine mesylate, Serada

FDA's Advisory Committee for Reproductive Health Drugs will meet on March 4 to discuss an NDA from Noven Pharmaceuticals Inc. for low-dose paroxetine...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >